Hsin Yang Liu
Corporate Officer/Principal chez TSH BIOPHARM CORPORATION LIMITED
Postes actifs de Hsin Yang Liu
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TSH BIOPHARM CORPORATION LIMITED | Corporate Officer/Principal | - | - |
| Directeur/Membre du Conseil | 24/06/2011 | 31/03/2020 | |
| Independent Dir/Board Member | 24/06/2011 | - | |
| Investor Relations Contact | 01/04/2020 | - | |
| Public Communications Contact | 01/04/2020 | - |
Historique de carrière de Hsin Yang Liu
Anciens postes connus de Hsin Yang Liu
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| REBER GENETICS CO LTD | Directeur/Membre du Conseil | 25/02/2014 | - |
| BODY ORGAN BIOMEDICAL CORP | Directeur Administratif | 01/05/2011 | - |
| Comptroller/Controller/Auditor | 01/05/2011 | - | |
| Directeur Financier/CFO | 01/05/2011 | - | |
| Public Communications Contact | 01/05/2011 | - |
Formation de Hsin Yang Liu
| National Taiwan University | Graduate Degree |
| Nankai University | Doctorate Degree |
Statistiques
Internationale
| Taïwan | 5 |
| Chine | 2 |
Opérationnelle
| Public Communications Contact | 2 |
| Director/Board Member | 2 |
| Chief Administrative Officer | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TSH BIOPHARM CORPORATION LIMITED | Health Technology |
| Entreprise privées | 2 |
|---|---|
Body Organ Biomedical Corp.
 Body Organ Biomedical Corp. BiotechnologyHealth Technology Body Organ Biomedical Corp. engages in the research, development, manufacture and sales of biomedical devices. It also provides regenerative solutions to restore tissue damage in orthopedics, dentistry, ophthalmology, reconstructive and general surgery. The company was founded on May 4, 2007 and is headquartered in Taipei, Taiwan. | Health Technology |
Reber Genetics Co., Ltd.
 Reber Genetics Co., Ltd. Pharmaceuticals: MajorHealth Technology Reber Genetics Co., Ltd. engages in the research, development, production, and sale of animal vaccines. Its products include PRRS and PCV2 subunit vaccines. The company was founded on April 18, 2008 and is headquartered in Taipei, Taiwan. | Health Technology |
- Bourse
- Insiders
- Hsin Yang Liu
- Expérience